3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Laryngeal Diseases
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Squamous Cell Carcinoma of Head and Neck
1
Papilloma
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Margins of Excision
1
Laryngeal Neoplasms
1
Esophageal Neoplasms
1
Interventions
Cisplatin
57
Radiotherapy
35
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
24
Radiation
21
Carboplatin
19
pembrolizumab
18
Specimen Handling
16
Platinum
14
Cetuximab
14
1,2-diaminocyclohexaneplatinum II citrate
14
Surveys and Questionnaires
13
Paclitaxel
13
Biopsy
11
Surgical Procedures, Operative
10
Fluorouracil
10
Docetaxel
9
Taxes
8
Nivolumab
8
Drug Therapy
8
Chemoradiotherapy
8
durvalumab
7
Fluorodeoxyglucose F18
7
Observation
6
Blood Specimen Collection
6
fludarabine
5
X-Rays
5
Immunohistochemistry
5
Cyclophosphamide
5
aldesleukin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
Narrow Band Imaging
×
Head & Neck
×
Clear all
NCT01175499
2014-08-19
TNFE-NBI
University of California, San Francisco
Phase NA
Withdrawn